Fineline Cube

Follow:
14422 Articles
NMPA Approves J&J's FGFR Kinase Inhibitor Balversa for Urothelial Carcinoma
CompanyDrug

NMPA Approves J&J’s FGFR Kinase Inhibitor Balversa for Urothelial Carcinoma

Doma Biopharma Receives FDA Clearance for DM002 Phase I Study
CompanyDrug

Doma Biopharma Receives FDA Clearance for DM002 Phase I Study-Fineline Info & Tech

GSK's Shingrix Prefilled Syringe Accepted for FDA Review
CompanyDrug

GSK’s Shingrix Prefilled Syringe Accepted for FDA Review

NHSA Launches Nationwide Self-Inspection Campaign on Medical Insurance Fund Usage
Policy / Regulatory

NHSA Launches Nationwide Self-Inspection Campaign on Medical Insurance Fund Usage

China's NHSA Implements New Regulations for Medical Insurance Payment Qualifications
Policy / Regulatory

China’s NHSA Implements New Regulations for Medical Insurance Payment Qualifications

Shenzhen Oculgen Secures Over RMB 100 Million in Series A Funding
Company

Shenzhen Oculgen Secures Over RMB 100 Million in Series A Funding

Fosun Pharmaceutical's FCN-437c Accepted for NMPA Review for Breast Cancer Treatment
CompanyDrug

Fosun Pharmaceutical’s FCN-437c Accepted for NMPA Review for Breast Cancer Treatment

Hengrui's SHR4640 Accepted for NMPA Review for Gout and Hyperuricemia Treatment
CompanyDrug

Hengrui’s SHR4640 Accepted for NMPA Review for Gout and Hyperuricemia Treatment

Keymed Biosciences Licenses CM313 to Timberlyne Therapeutics for Global Development
CompanyDeals

Keymed Biosciences Licenses CM313 to Timberlyne Therapeutics for Global Development

Biocytogen and SOTIO Biotech Partner on Colorectal Cancer ADC Candidate SOT109
CompanyDeals

Biocytogen and SOTIO Biotech Partner on Colorectal Cancer ADC Candidate SOT109

Novo Nordisk and Valo Health Expand Partnership to Develop Treatments for Obesity and Diabetes
CompanyDeals

Novo Nordisk and Valo Health Expand Partnership to Develop Treatments for Obesity and Diabetes

Immunochina Pharmaceuticals Raises Series E Funding for CAR-T Therapy IM19
CompanyDeals

Immunochina Pharmaceuticals Raises Series E Funding for CAR-T Therapy IM19